Morgan, Sarah L.
Singh, Jasvinder A. http://orcid.org/0000-0003-3485-0006
Article History
First Online: 28 January 2021
Competing interests
: J.A.S. has received consultant fees from the ACR, Adept Field Solutions, Clearview Healthcare Partners, Clinical Care Options, Crealta/Horizon, Fidia, Focus Forward, Medisys, Medscape, Navigant Consulting, the National Institutes of Health, Practice Point Communications, Putnam Associates, Spherix, Trio health, UBM LLC and WebMD. J.A.S. owns stock options in Charlotte’s Web Holdings, Inc., TPT Global Tech and Vaxart Pharmaceuticals. J.A.S. previously owned stock options in Amarin, Moderna Pharmaceuticals and Viking. J.A.S. is on the speaker’s bureau of Simply Speaking. J.A.S. is a member of the executive of Outcomes Measures in Rheumatology (OMERACT), an organization that receives arms-length funding from 12 companies. S.L.M. declares no competing interests.